Professor | Liang Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Liang Li
Contact Information	lli@smu.edu.cn
Language ability	Chinese, English
Province	Guangdong

Upload Avatar (500 x 500)

Name

Liang Li

Contact Information

lli@smu.edu.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Southern Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1993-09 to 1998-06: Bachelor's in Clinical Medicine from North China Coal Medical College 1998-09 to 2003-06: Doctorate in Pathology and Pathophysiology from First Military Medical University
Work Experience	2003-07 to 2006-12: Lecturer at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital 2007-01 to 2012-12: Associate Professor at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital 2013-01 to Present: Professor, Deputy Director, Director at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital
Awards	National Hundred, Thousand, and Ten Thousand Talent Project (2019) Recipient of Government Special Allowance (2020) Ministry of Education 'New Century Excellent Talent' (2013) Guangdong Province 'Pearl River Scholar' Distinguished Professor (2016) Fourth National Famous Doctor. Outstanding Style (2020) China Outstanding Young Pathologist Award (2015) Ministry of Education 'Basic Discipline Top-notch Student Training Program 2.0' Excellent Teacher (2021) Southern Medical University Excellent Teacher (2019) Guangdong Province Natural Science First Prize (First Completer, 2022) Guangdong Province Science and Technology Progress First Prize and Chinese Medical Science Second Prize (Third Completer, 2014)

University/Lab Affiliation and Title

Southern Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1993-09 to 1998-06: Bachelor's in Clinical Medicine from North China Coal Medical College
1998-09 to 2003-06: Doctorate in Pathology and Pathophysiology from First Military Medical University

Work Experience

2003-07 to 2006-12: Lecturer at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital
2007-01 to 2012-12: Associate Professor at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital
2013-01 to Present: Professor, Deputy Director, Director at Department of Pathology, Basic Medical College, Southern Medical University/Southern Hospital

Awards

National Hundred, Thousand, and Ten Thousand Talent Project (2019)
Recipient of Government Special Allowance (2020)
Ministry of Education 'New Century Excellent Talent' (2013)
Guangdong Province 'Pearl River Scholar' Distinguished Professor (2016)
Fourth National Famous Doctor. Outstanding Style (2020)
China Outstanding Young Pathologist Award (2015)
Ministry of Education 'Basic Discipline Top-notch Student Training Program 2.0' Excellent Teacher (2021)
Southern Medical University Excellent Teacher (2019)
Guangdong Province Natural Science First Prize (First Completer, 2022)
Guangdong Province Science and Technology Progress First Prize and Chinese Medical Science Second Prize (Third Completer, 2014)

Areas of Focus	Research on molecular mechanisms of tumor metastasis and drug resistance and new diagnostic methods
Publications	Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis., Zeng ZC, Li YL, Pan YJ, Lan XL, Sun JB, Zhou K, Liu XL, Ren XL, Wang FF, Hu JL, Zhu XH, Yang W, Liao WT, Li GX, Ding YQ, Liang L., 2018 CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer., Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, Liao WT, Ding YQ, Liang L., 2019 A multilocus blood-based assay targeting circulating tumor DNA methylation enable early detection and early relapse prediction of colorectal cancer., Cai GX, Cai MY, Feng ZQ, Liu R, Liang L, Zhou PH, the ColonAiQ Group., 2021 COMMD10 inhibits HIF1alpha/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma., Yang M, Wu XX, Hu JL, Wang YQ, Wang Y, Wang XQ, Zhang LS, Huang WQ, Chen M, Xiao NJ, Dai YM, Liang HZ, Huang WQ, Yuan L, Li L, Chen LH, Liu LY, Liang L, Guan J., 2022 Hybrid AI assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears., Zhu XH, Li XM, Ong Kokhaur, Zhang WL, Li WC, Li LJ, Young David, Su YJ, Shang B, Peng LG, Xiong W, Liu YK, Liao WT, Xu JJ, Wang FF, Liao Q, Shi JY, Zou ZJ, Zhong WL, Liang XR, Han H, Zhang Y, Tang N, Hu Aixia, Gao HY, Cheng ZQ, Liang L, Yu WM, Ding YQ., 2021 Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA., Wang W, Zhu X, Zhang X, Lei C, Zeng Z, Lan X, Cui W, Wang F, Xu S, Zhou J, Wu X, Deng H, Li X, Fan J, Ding Y, Huang Z, Liang L., 2022

Areas of Focus

Research on molecular mechanisms of tumor metastasis and drug resistance and new diagnostic methods

Publications

Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis., Zeng ZC, Li YL, Pan YJ, Lan XL, Sun JB, Zhou K, Liu XL, Ren XL, Wang FF, Hu JL, Zhu XH, Yang W, Liao WT, Li GX, Ding YQ, Liang L., 2018
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer., Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, Liao WT, Ding YQ, Liang L., 2019
A multilocus blood-based assay targeting circulating tumor DNA methylation enable early detection and early relapse prediction of colorectal cancer., Cai GX, Cai MY, Feng ZQ, Liu R, Liang L, Zhou PH, the ColonAiQ Group., 2021
COMMD10 inhibits HIF1alpha/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma., Yang M, Wu XX, Hu JL, Wang YQ, Wang Y, Wang XQ, Zhang LS, Huang WQ, Chen M, Xiao NJ, Dai YM, Liang HZ, Huang WQ, Yuan L, Li L, Chen LH, Liu LY, Liang L, Guan J., 2022
Hybrid AI assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears., Zhu XH, Li XM, Ong Kokhaur, Zhang WL, Li WC, Li LJ, Young David, Su YJ, Shang B, Peng LG, Xiong W, Liu YK, Liao WT, Xu JJ, Wang FF, Liao Q, Shi JY, Zou ZJ, Zhong WL, Liang XR, Han H, Zhang Y, Tang N, Hu Aixia, Gao HY, Cheng ZQ, Liang L, Yu WM, Ding YQ., 2021
Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA., Wang W, Zhu X, Zhang X, Lei C, Zeng Z, Lan X, Cui W, Wang F, Xu S, Zhou J, Wu X, Deng H, Li X, Fan J, Ding Y, Huang Z, Liang L., 2022

Tumor Metastasis Tumor Immune Microenvironment Tumor Drug Resistance Tumor Diagnosis Digestive Tract Tumors Molecular Mechanisms Diagnostic Methods Cancer Research Metastasis Drug Resistance

Genze Shao - Peking University

Luqing Zhao - Central South University

Shi Feng - Central South University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us